Exchange Traded Concepts, LLC Viatris Inc Transaction History

Exchange Traded Concepts, LLC

$7.62 Billion
Q2 2025

A detailed history of Exchange Traded Concepts, LLC transactions in Viatris Inc stock. As of the latest transaction made, Exchange Traded Concepts, LLC holds 79,754 shares of VTRS stock, worth $739,319. This represents 0.01% of its overall portfolio holdings.

Number of Shares

79,754

Previous 155,455 48.7%

Holding current value

$739,319

Previous $1.35 Million 47.42%

% of portfolio

0.01%

Previous 0.02%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 10, 2025	SELL	$7.26 - $9.12 $549,589 - $690,393	-75,701 Reduced 48.7%	79,754 $712,000
Q1 2025 Apr 17, 2025	BUY	$8.68 - $12.42 $165,692 - $237,085	19,089 Added 14.0%	155,455 $1.35 Million
Q4 2024 Jan 21, 2025	BUY	$11.32 - $13.37 $624,965 - $738,144	55,209 Added 68.03%	136,366 $1.7 Million
Q3 2024 Oct 10, 2024	BUY	$10.32 - $12.13 $205,987 - $242,114	19,960 Added 32.62%	81,157 $942,000
Q2 2024 Aug 13, 2024	SELL	$10.05 - $12.02 $1.6 Million - $1.92 Million	-159,603 Reduced 72.28%	61,197 $650,000
Q1 2024 Apr 15, 2024	BUY	$11.27 - $13.53 $2.48 Million - $2.97 Million	219,725 Added 20439.53%	220,800 $2.64 Million
Q4 2023 Jan 05, 2024	BUY	$8.77 - $10.85 $9,427 - $11,663	1,075 New	1,075 $11,000
Q2 2022 Jul 20, 2022	BUY	$9.95 - $12.27 $13,024 - $16,061	1,309 New	1,309 $14,000
Q3 2021 Oct 18, 2021	SELL	$13.25 - $15.13 $367,276 - $419,388	-27,719 Closed	0 $0
Q2 2021 Jul 30, 2021	BUY	$12.97 - $16.15 $26,134 - $32,542	2,015 Added 7.84%	27,719 $396,000
Q1 2021 Apr 20, 2021	SELL	$13.59 - $18.54 $1,861 - $2,539	-137 Reduced 0.53%	25,704 $359,000
Q4 2020 Jan 19, 2021	BUY	$14.3 - $18.74 $369,526 - $484,260	25,841 New	25,841 $484,000

Others Institutions Holding VTRS

# of Institutions

1,126

Shares Held

958M

Call Options Held

4.15M

Put Options Held

2.65M

View Full List

About Viatris Inc

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $11.2B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

More about VTRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exchange Traded Concepts, LLC with notifications on news.

Account

Exchange Traded Concepts, LLC Viatris Inc Transaction History